Clearstead Advisors, LLC Pulmonx Corp Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Clearstead Advisors, LLC holds 1 shares of LUNG stock, worth $2. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$2% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LUNG
# of Institutions
119Shares Held
32.5MCall Options Held
0Put Options Held
0-
Primecap Management CO Pasadena, CA4.96MShares$10.4 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.56MShares$7.43 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$5.58 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.24MShares$4.69 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.89MShares$3.95 Million0.11% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $77.9M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...